Partner News | Published: Wednesday, August 23, 2023
MedAxiom Industry Partner, Echo IQ, an artificial intelligence (AI) and medical technology company, will be presenting findings in two late-breaking science presentations at the European Society of Cardiology Congress (“ESC”) Congress in Amsterdam, Netherlands in August. This is the second consecutive year that Echo IQ will be featured in this way on the world stage in front of leading cardiologists and researchers. They will also be sharing the latest news and updates live from the conference.
Prof. Geoff Strange, PhD, FCANZ, FPHSANZ, from the University of Notre Dame, and Echo IQ chief research and strategy officer, has been invited to present: “Detect Aortic Stenosis by Echo with Artificial Intelligence” on Aug. 27, 2023. This work shows how AI and technology-aided detection of severe aortic stenosis can enhance identification of disease versus human-only detection and will include the complete results of the previously announced St Vincent’s Hospital clinical study.
Professor David Playford, MBBS, FRACP, PhD, FCSANZ, FESC, FACC, Echo IQ’s chief medical officer (and chair of cardiology, The University of Notre Dame) has been invited to present at the same conference. He will be presenting: “MR-NEDA - Prognosis of mild to severe Mitral Regurgitation” on Aug. 25, 2023. This work was completed with significant contribution from Echo IQ, using natural language processing analysis of echocardiographic reports.
As part of the cardiovascular innovation community, the Echo IQ team will be on the ground, sharing key information and opinions from leaders around the world on their LinkedIn and Twitter channels. Get the scoop on what’s happening at ESC at echoiq.ai/esc and follow the team on social media for all the breakthrough news.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.